Selected research
Industry Research
Absorbable Hemostatic Agents Industry Research Report 2026
Market perspective
The global Absorbable Hemostatic Agents market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Absorbable Hemostatic Agents is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Absorbable Hemostatic Agents is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Absorbable Hemostatic Agents is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Absorbable Hemostatic Agents include BD, Biotemed, Cura Medical, Curasan AG, Foryou Medical, GELITA MEDICAL, Meril Life Sciences, Saikesaisi Holdings Group and Zhonghui Shengxi, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Absorbable Hemostatic Agents market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Absorbable Hemostatic Agents Market by Company
BD
Biotemed
Cura Medical
Curasan AG
Foryou Medical
GELITA MEDICAL
Meril Life Sciences
Saikesaisi Holdings Group
Zhonghui Shengxi
Baxter
Beijing Taikesiman
B.Braun
Beijing Datsing Bio-tech
Guizhou Jin Jiu Biotech
Johnson & Johnson
Absorbable Hemostatic Agents Segment by Type
Gauze
Gelatin Sponge
Powder
Other
Absorbable Hemostatic Agents Segment by Application
Hospital
Clinics
Others
Absorbable Hemostatic Agents Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Absorbable Hemostatic Agents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Absorbable Hemostatic Agents and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Absorbable Hemostatic Agents.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Absorbable Hemostatic Agents manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Absorbable Hemostatic Agents by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Absorbable Hemostatic Agents in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Gauze
- Gelatin Sponge
- Powder
- Other
Applications
- Hospital
- Clinics
- Others
Companies covered
- BD
- Biotemed
- Cura Medical
- Curasan AG
- Foryou Medical
- GELITA MEDICAL
- Meril Life Sciences
- Saikesaisi Holdings Group
- Zhonghui Shengxi
- Baxter
- Beijing Taikesiman
- B.Braun
- Beijing Datsing Bio-tech
- Guizhou Jin Jiu Biotech
- Johnson & Johnson
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Absorbable Hemostatic Agents Market Size (2021-2032)
- 2.2.2 Global Absorbable Hemostatic Agents Sales (2021-2032)
- 2.2.3 Global Absorbable Hemostatic Agents Market Average Price (2021-2032)
- 2.3 Absorbable Hemostatic Agents by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Gauze
- 2.3.3 Gelatin Sponge
- 2.3.4 Powder
- 2.3.5 Other
- 2.4 Absorbable Hemostatic Agents by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Clinics
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Absorbable Hemostatic Agents Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Absorbable Hemostatic Agents Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Absorbable Hemostatic Agents Revenue of Manufacturers (2021-2026)
- 3.4 Global Absorbable Hemostatic Agents Average Price by Manufacturers (2021-2026)
- 3.5 Global Absorbable Hemostatic Agents Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Absorbable Hemostatic Agents, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Absorbable Hemostatic Agents, Product Type & Application
- 3.8 Global Manufacturers of Absorbable Hemostatic Agents, Established Date
- 3.9 Global Absorbable Hemostatic Agents Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 BD
- 4.1.1 BD Company Information
- 4.1.2 BD Business Overview
- 4.1.3 BD Absorbable Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 BD Absorbable Hemostatic Agents Product Portfolio
- 4.1.5 BD Recent Developments
- 4.2 Biotemed
- 4.2.1 Biotemed Company Information
- 4.2.2 Biotemed Business Overview
- 4.2.3 Biotemed Absorbable Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Biotemed Absorbable Hemostatic Agents Product Portfolio
- 4.2.5 Biotemed Recent Developments
- 4.3 Cura Medical
- 4.3.1 Cura Medical Company Information
- 4.3.2 Cura Medical Business Overview
- 4.3.3 Cura Medical Absorbable Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Cura Medical Absorbable Hemostatic Agents Product Portfolio
- 4.3.5 Cura Medical Recent Developments
- 4.4 Curasan AG
- 4.4.1 Curasan AG Company Information
- 4.4.2 Curasan AG Business Overview
- 4.4.3 Curasan AG Absorbable Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Curasan AG Absorbable Hemostatic Agents Product Portfolio
- 4.4.5 Curasan AG Recent Developments
- 4.5 Foryou Medical
- 4.5.1 Foryou Medical Company Information
- 4.5.2 Foryou Medical Business Overview
- 4.5.3 Foryou Medical Absorbable Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Foryou Medical Absorbable Hemostatic Agents Product Portfolio
- 4.5.5 Foryou Medical Recent Developments
- 4.6 GELITA MEDICAL
- 4.6.1 GELITA MEDICAL Company Information
- 4.6.2 GELITA MEDICAL Business Overview
- 4.6.3 GELITA MEDICAL Absorbable Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 GELITA MEDICAL Absorbable Hemostatic Agents Product Portfolio
- 4.6.5 GELITA MEDICAL Recent Developments
- 4.7 Meril Life Sciences
- 4.7.1 Meril Life Sciences Company Information
- 4.7.2 Meril Life Sciences Business Overview
- 4.7.3 Meril Life Sciences Absorbable Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Meril Life Sciences Absorbable Hemostatic Agents Product Portfolio
- 4.7.5 Meril Life Sciences Recent Developments
- 4.8 Saikesaisi Holdings Group
- 4.8.1 Saikesaisi Holdings Group Company Information
- 4.8.2 Saikesaisi Holdings Group Business Overview
- 4.8.3 Saikesaisi Holdings Group Absorbable Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Saikesaisi Holdings Group Absorbable Hemostatic Agents Product Portfolio
- 4.8.5 Saikesaisi Holdings Group Recent Developments
- 4.9 Zhonghui Shengxi
- 4.9.1 Zhonghui Shengxi Company Information
- 4.9.2 Zhonghui Shengxi Business Overview
- 4.9.3 Zhonghui Shengxi Absorbable Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Zhonghui Shengxi Absorbable Hemostatic Agents Product Portfolio
- 4.9.5 Zhonghui Shengxi Recent Developments
- 4.10 Baxter
- 4.10.1 Baxter Company Information
- 4.10.2 Baxter Business Overview
- 4.10.3 Baxter Absorbable Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Baxter Absorbable Hemostatic Agents Product Portfolio
- 4.10.5 Baxter Recent Developments
- 4.11 Beijing Taikesiman
- 4.11.1 Beijing Taikesiman Company Information
- 4.11.2 Beijing Taikesiman Business Overview
- 4.11.3 Beijing Taikesiman Absorbable Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Beijing Taikesiman Absorbable Hemostatic Agents Product Portfolio
- 4.11.5 Beijing Taikesiman Recent Developments
- 4.12 B.Braun
- 4.12.1 B.Braun Company Information
- 4.12.2 B.Braun Business Overview
- 4.12.3 B.Braun Absorbable Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 B.Braun Absorbable Hemostatic Agents Product Portfolio
- 4.12.5 B.Braun Recent Developments
- 4.13 Beijing Datsing Bio-tech
- 4.13.1 Beijing Datsing Bio-tech Company Information
- 4.13.2 Beijing Datsing Bio-tech Business Overview
- 4.13.3 Beijing Datsing Bio-tech Absorbable Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Beijing Datsing Bio-tech Absorbable Hemostatic Agents Product Portfolio
- 4.13.5 Beijing Datsing Bio-tech Recent Developments
- 4.14 Guizhou Jin Jiu Biotech
- 4.14.1 Guizhou Jin Jiu Biotech Company Information
- 4.14.2 Guizhou Jin Jiu Biotech Business Overview
- 4.14.3 Guizhou Jin Jiu Biotech Absorbable Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Guizhou Jin Jiu Biotech Absorbable Hemostatic Agents Product Portfolio
- 4.14.5 Guizhou Jin Jiu Biotech Recent Developments
- 4.15 Johnson & Johnson
- 4.15.1 Johnson & Johnson Company Information
- 4.15.2 Johnson & Johnson Business Overview
- 4.15.3 Johnson & Johnson Absorbable Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Johnson & Johnson Absorbable Hemostatic Agents Product Portfolio
- 4.15.5 Johnson & Johnson Recent Developments
5 Global Absorbable Hemostatic Agents Market Scenario by Region
- 5.1 Global Absorbable Hemostatic Agents Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Absorbable Hemostatic Agents Sales by Region: 2021-2032
- 5.2.1 Global Absorbable Hemostatic Agents Sales by Region: 2021-2026
- 5.2.2 Global Absorbable Hemostatic Agents Sales by Region: 2027-2032
- 5.3 Global Absorbable Hemostatic Agents Revenue by Region: 2021-2032
- 5.3.1 Global Absorbable Hemostatic Agents Revenue by Region: 2021-2026
- 5.3.2 Global Absorbable Hemostatic Agents Revenue by Region: 2027-2032
- 5.4 North America Absorbable Hemostatic Agents Market Facts & Figures by Country
- 5.4.1 North America Absorbable Hemostatic Agents Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Absorbable Hemostatic Agents Sales by Country (2021-2032)
- 5.4.3 North America Absorbable Hemostatic Agents Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Absorbable Hemostatic Agents Market Facts & Figures by Country
- 5.5.1 Europe Absorbable Hemostatic Agents Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Absorbable Hemostatic Agents Sales by Country (2021-2032)
- 5.5.3 Europe Absorbable Hemostatic Agents Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Absorbable Hemostatic Agents Market Facts & Figures by Country
- 5.6.1 Asia Pacific Absorbable Hemostatic Agents Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Absorbable Hemostatic Agents Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Absorbable Hemostatic Agents Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Absorbable Hemostatic Agents Market Facts & Figures by Country
- 5.7.1 South America Absorbable Hemostatic Agents Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Absorbable Hemostatic Agents Sales by Country (2021-2032)
- 5.7.3 South America Absorbable Hemostatic Agents Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Absorbable Hemostatic Agents Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Absorbable Hemostatic Agents Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Absorbable Hemostatic Agents Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Absorbable Hemostatic Agents Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Absorbable Hemostatic Agents Sales by Type (2021-2032)
- 6.1.1 Global Absorbable Hemostatic Agents Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Absorbable Hemostatic Agents Sales Market Share by Type (2021-2032)
- 6.2 Global Absorbable Hemostatic Agents Revenue by Type (2021-2032)
- 6.2.1 Global Absorbable Hemostatic Agents Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Absorbable Hemostatic Agents Revenue Market Share by Type (2021-2032)
- 6.3 Global Absorbable Hemostatic Agents Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Absorbable Hemostatic Agents Sales by Application (2021-2032)
- 7.1.1 Global Absorbable Hemostatic Agents Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Absorbable Hemostatic Agents Sales Market Share by Application (2021-2032)
- 7.2 Global Absorbable Hemostatic Agents Revenue by Application (2021-2032)
- 7.2.1 Global Absorbable Hemostatic Agents Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Absorbable Hemostatic Agents Revenue Market Share by Application (2021-2032)
- 7.3 Global Absorbable Hemostatic Agents Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Absorbable Hemostatic Agents Value Chain Analysis
- 8.1.1 Absorbable Hemostatic Agents Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Absorbable Hemostatic Agents Production Mode & Process
- 8.2 Absorbable Hemostatic Agents Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Absorbable Hemostatic Agents Distributors
- 8.2.3 Absorbable Hemostatic Agents Customers
9 Global Absorbable Hemostatic Agents Analyzing Market Dynamics
- 9.1 Absorbable Hemostatic Agents Industry Trends
- 9.2 Absorbable Hemostatic Agents Industry Drivers
- 9.3 Absorbable Hemostatic Agents Industry Opportunities and Challenges
- 9.4 Absorbable Hemostatic Agents Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst